Overview

Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the effect of subject knowledge of their disease status on persistence in subjects receiving Actonel 5 mg daily over a 12-month period for the prevention and treatment of GIO.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Glucocorticoids
Risedronate Sodium
Risedronic Acid